The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion - EP3230316

The patent EP3230316 was granted to Bayer Healthcare on Jan 5, 2022. The application was filed on Dec 10, 2015 under application number EP15819965A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3230316

BAYER HEALTHCARE
Application Number
EP15819965A
Filing Date
Dec 10, 2015
Status
Granted And Under Opposition
Dec 3, 2021
Publication Date
Jan 5, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AMGENOct 5, 2022UEXKULL & STOLBERGADMISSIBLE
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBOct 5, 2022KUTTENKEULERADMISSIBLE
BOULT WADE TENNANTOct 5, 2022-ADMISSIBLE
MAIWALDOct 5, 2022MAIWALDWITHDRAWN
WITHERS & ROGERSOct 4, 2022POHLMANADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBOct 4, 2022WICHMANNADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0075319
DESCRIPTIONWO2007112675
DESCRIPTIONWO9818480
DESCRIPTIONWO9845331
INTERNATIONAL-SEARCH-REPORTWO02062386
OPPOSITIONWO2016094673

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents